Cargando…
Melatonin is a potential inhibitor of ovarian cancer: molecular aspects
Ovarian cancer is one of the most common causes of morbidity related to gynecologic malignancies. Possible risk factors are including hereditary ovarian cancer, obesity, diabetes mellitus, alcohol consumption, aging, and smoking. Various molecular signaling pathways including inflammation, oxidative...
Autores principales: | Zare, Hadis, Shafabakhsh, Rana, Reiter, Russel J., Asemi, Zatollah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434863/ https://www.ncbi.nlm.nih.gov/pubmed/30914056 http://dx.doi.org/10.1186/s13048-019-0502-8 |
Ejemplares similares
-
Resveratrol is a promising agent for colorectal cancer prevention and treatment: focus on molecular mechanisms
por: Honari, Mohadese, et al.
Publicado: (2019) -
Quercetin: a natural compound for ovarian cancer treatment
por: Shafabakhsh, Rana, et al.
Publicado: (2019) -
Melatonin and cancer suppression: insights into its effects on DNA methylation
por: Davoodvandi, Amirhossein, et al.
Publicado: (2022) -
Melatonin: an anti-tumor agent for osteosarcoma
por: Fathizadeh, Hadis, et al.
Publicado: (2019) -
Melatonin and non-small cell lung cancer: new insights into signaling pathways
por: Pourhanifeh, Mohammad Hossein, et al.
Publicado: (2019)